| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Prospective Study |
| Article Title |
Anti-vaccine antibodies against measles, rubella, parotitis and hepatitis B in children with inflammatory bowel disease and healthy controls
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Elizaveta Makarova, Olga Goleva, Tatiana Gabrusskaya, Natalia Ulanova, Natalia Volkova, Elena Shilova, Maria Tolkmit, Maria Revnova, Susanna Kharit and Mikhail Kostik |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mikhail Kostik, MD, PhD, Professor, Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Lytovskaya 2, Saint-Petersburg 194100, Russia. kost-mikhail@yandex.ru |
| Key Words |
Inflammatory bowel diseases; Vaccine; Measles; Mumps; Rubella; Hepatitis B; Antibodies; Anti-vaccine antibodies; Vaccine coverage; Children |
| Core Tip |
Improving vaccination, engaging the trust of parents and physicians in vaccination, and its safety and efficacy in children with immune-mediated diseases could decrease the infection risks. This study showed the vaccine coverage, the predictors of incomplete vaccination, and non-protective levels of post-vaccine antibodies. The younger onset of the disease onset disrupts the following scheduled vaccination. Avoiding corticosteroid treatment, regular assessment of anti-vaccine antibodies, and encouragement of vaccination are the main goals for managing patients with inflammatory bowel diseases. |
| Publish Date |
2025-06-16 10:38 |
| Citation |
<p>Makarova E, Goleva O, Gabrusskaya T, Ulanova N, Volkova N, Shilova E, Tolkmit M, Revnova M, Kharit S, Kostik M. Anti-vaccine antibodies against measles, rubella, parotitis and hepatitis B in children with inflammatory bowel disease and healthy controls. <i>World J Clin Pediatr</i> 2025; 14(3): 104704</p> |
| URL |
https://www.wjgnet.com/2219-2808/full/v14/i3/104704.htm |
| DOI |
https://dx.doi.org/10.5409/wjcp.v14.i3.104704 |
